Improved early right ventricular function recovery but increased complications with catheter-directed interventions compared with anticoagulation alone for submassive pulmonary embolism
- PMID: 27318043
- PMCID: PMC7151648
- DOI: 10.1016/j.jvsv.2015.11.003
Improved early right ventricular function recovery but increased complications with catheter-directed interventions compared with anticoagulation alone for submassive pulmonary embolism
Abstract
Objective: The purpose of this study was to determine the short-term and midterm outcomes of catheter-directed intervention (CDI) compared with anticoagulation (AC) alone in patients with submassive pulmonary embolism (sPE).
Methods: This was a retrospective review of all patients treated for sPE between January 2009 and October 2014. Two groups were identified on the basis of the therapy: AC and CDI. End points included complications, mortality, and change in echocardiographic parameters. Standard statistical techniques were used.
Results: There were 64 patients who received AC and 64 patients who received CDI (five were initially treated with AC but did not improve or worsened; six received ≤8 mg of tissue plasminogen activator). Most baseline characteristics, including the Pulmonary Embolism Severity Index, were similar among the AC and CDI groups. There was no difference in PE-related death (one in each group) or major bleeding events (three in the AC group, four in the CDI group), but CDIs had two additional procedural complications that required open heart surgery. CDIs showed significantly more minor bleeding events (6 vs 0; P = .028) and significantly shorter intensive care unit stay (2.7 ± 2.1 vs 5.6 ± 7.5 days; P = .04). The mean difference in right ventricular/left ventricular ratio from baseline to the first subsequent echocardiogram (within 30 days) showed a trend for higher reduction in favor of CDI (AC, 0.17 ± 0.12; CDI, 0.27 ± 0.15; P = .076). Between 3 and 8 months, significant improvement was evident within groups in all assessed right-sided heart echocardiographic parameters, but there was no difference between groups. Pulmonary hypertension (pulmonary artery pressure >40 mm Hg) was present in 7 of 15 of the AC group vs 6 of 19 of the CDI group (P = .484). During the follow-up, dyspnea or oxygen dependence, not existing before the index PE event, was recorded in 5 of 49 (10.2%) of the AC patients and 8 of 52 (15.4%) of the CDI patients (P = .556).
Conclusions: CDI for sPE can result in faster restoration of right ventricular function and shorter intensive care unit stay, but at the cost of a higher complication rate, with similar midterm outcomes compared with AC alone. A potential effect of CDI on mortality and pulmonary hypertension needs further investigation through larger studies.
Copyright © 2016 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
The editors and reviewers of this article have no relevant financial relationships to disclose per the Journal policy that requires reviewers to decline review of any manuscript for which they may have a conflict of interest.
Author conflict of interest: none.
Comment in
-
Discussion.J Vasc Surg Venous Lymphat Disord. 2016 Jul;4(3):275. doi: 10.1016/j.jvsv.2015.11.006. Epub 2016 Apr 14. J Vasc Surg Venous Lymphat Disord. 2016. PMID: 27318044 No abstract available.
Similar articles
-
Catheter-directed interventions compared with systemic thrombolysis achieve improved ventricular function recovery at a potentially lower complication rate for acute pulmonary embolism.J Vasc Surg Venous Lymphat Disord. 2018 Jul;6(4):425-432. doi: 10.1016/j.jvsv.2017.12.058. Epub 2018 Mar 31. J Vasc Surg Venous Lymphat Disord. 2018. PMID: 29615372 Free PMC article.
-
Ultrasound-assisted catheter-directed thrombolysis versus anticoagulation alone for management of submassive pulmonary embolism.J Cardiol. 2022 Nov;80(5):441-448. doi: 10.1016/j.jjcc.2022.04.008. Epub 2022 May 25. J Cardiol. 2022. PMID: 35643741
-
Echocardiographic assessment with right ventricular function improvement following ultrasound-accelerated catheter-directed thrombolytic therapy in submassive pulmonary embolism.Vascular. 2018 Jun;26(3):271-277. doi: 10.1177/1708538117733645. Epub 2017 Sep 24. Vascular. 2018. PMID: 28945166
-
Safety of catheter-directed thrombolysis for massive and submassive pulmonary embolism: Results of a multicenter registry and meta-analysis.Catheter Cardiovasc Interv. 2017 Mar 1;89(4):754-760. doi: 10.1002/ccd.26900. Epub 2017 Feb 1. Catheter Cardiovasc Interv. 2017. PMID: 28145042 Review.
-
Meta-Analysis of Catheter Directed Ultrasound-Assisted Thrombolysis in Pulmonary Embolism.Am J Cardiol. 2019 Nov 1;124(9):1470-1477. doi: 10.1016/j.amjcard.2019.07.040. Epub 2019 Aug 7. Am J Cardiol. 2019. PMID: 31492420 Review.
Cited by
-
Catheter-directed Thrombolysis versus Systemic Anticoagulation for Submassive Pulmonary Embolism: A Meta-Analysis.Curr Cardiol Rev. 2022;18(1):112-117. doi: 10.2174/1573403X17666210603114116. Curr Cardiol Rev. 2022. PMID: 34082686 Free PMC article.
-
Ekosonic Endovascular System (EKOS) in a trauma patient with intracranial bleed, recent major surgery, and massive pulmonary embolus: A case report.Radiol Case Rep. 2017 Nov 7;13(1):156-160. doi: 10.1016/j.radcr.2017.10.005. eCollection 2018 Feb. Radiol Case Rep. 2017. PMID: 29487650 Free PMC article.
-
Safety and efficacy of catheter-directed therapy versus anticoagulation alone in a higher-risk acute pulmonary embolism population.J Thromb Thrombolysis. 2021 Nov;52(4):1151-1159. doi: 10.1007/s11239-021-02481-9. Epub 2021 May 25. J Thromb Thrombolysis. 2021. PMID: 34036485 Free PMC article.
-
Outcomes of catheter-directed interventions in high-risk pulmonary embolism-a retrospective analysis.Acta Anaesthesiol Scand. 2021 Apr;65(4):499-506. doi: 10.1111/aas.13753. Epub 2020 Dec 25. Acta Anaesthesiol Scand. 2021. PMID: 33245785 Free PMC article.
-
Anticoagulant Impact on Clinical Outcomes of Pulmonary Embolism Compared With Thrombolytic Therapy; Meta-Analysis.Clin Cardiol. 2024 Sep;47(9):e70016. doi: 10.1002/clc.70016. Clin Cardiol. 2024. PMID: 39267429 Free PMC article.
References
-
- Kahn SR, Houweling AH, Granton J, Rudski L, Dennie C, Hirsch A. Long-term outcomes after pulmonary embolism: current knowledge and future research. Blood Coagul Fibrinolysis 2014;25: 407–15. - PubMed
-
- Laporte S, Mismetti P, Decousus H, Uresandi F, Otero R, Lobo JL, et al. Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) registry. Circulation 2008;117:1711–6. - PubMed
-
- Jaff MR, McMurtry MS, Archer SL, Cushman M, Goldenberg N, Goldhaber SZ, et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation 2011;123:1788–830. - PubMed
-
- Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141:e419S–94S. - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical